Literature DB >> 13618501

Histological changes in the lung in diseases associated with pulmonary venous hypertension.

D HEATH, J E EDWARDS.   

Abstract

Entities:  

Keywords:  CARDIOVASCULAR DEFECTS, CONGENITAL/complications; HYPERTENSION/pathology; LUNGS/pathology

Mesh：

Year:  1959        PMID： 13618501     DOI： 10.1016/s0007-0971(59)80105-4

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN： 0007-0971


× No keyword cloud information.
  10 in total

1.  [A primary isolated obliterating pulmonary vein change as a cause of chronic cor pulmonale].

Authors:  K BUERKI
Journal:  Arch Kreislaufforsch       Date:  1963-04

2.  [Hypertensive changes of the pulmonary vessels].

Authors:  B Bednár
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1965-10-18

3.  Chronic idiopathic pulmonary hilar fibrosis. A clinicopathological entity.

Authors:  M H Yacoub; V C Thompson
Journal:  Thorax       Date:  1971-07       Impact factor: 9.139

4.  Assessment of homograft replacement of mitral valve by chest radiographs.

Authors:  C Salzmann; G C Sutton; K Chatterjee; I H Kerr; G A Miller
Journal:  Br Heart J       Date:  1972-02

5.  Lung mast cells in plexogenic pulmonary arteriopathy.

Authors:  D Heath; M Yacoub
Journal:  J Clin Pathol       Date:  1991-12       Impact factor: 3.411

6.  Quantitative determination of regional extravascular lung water and regional blood volume in congestive heart failure.

Authors:  O H Schober; G J Meyer; C Bossaller; H Creutzig; P R Lichtlen; H Hundeshagen
Journal:  Eur J Nucl Med       Date:  1985

7.  Pulmonary microvascular permeability in patients with severe mitral stenosis.

Authors:  S W Davies; P Wilkinson; J Keegan; J Bailey; A D Timmis; J A Wedzicha; R M Rudd
Journal:  Br Heart J       Date:  1991-02

8.  Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failure.

Authors:  T P Chua; S D Anker; D Harrington; A J Coats
Journal:  Br Heart J       Date:  1995-10

9.  Pulmonary venous remodeling in COPD-pulmonary hypertension and idiopathic pulmonary arterial hypertension.

Authors:  Kasper Hasseriis Andersen; Claus Bøgelund Andersen; Finn Gustafsson; Jørn Carlsen
Journal:  Pulm Circ       Date:  2017-05-24       Impact factor: 3.017

10.  Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial.

Authors:  Ines Garcia-Lunar; Isabel Blanco; Leticia Fernández-Friera; Susanna Prat-Gonzàlez; Paloma Jordà; Javier Sánchez; Daniel Pereda; Sandra Pujadas; Mercedes Rivas; Eduard Solé-Gonzalez; Jorge Vázquez; Zorba Blázquez; Juan García-Picart; Pedro Caravaca; Noemí Escalera; Pablo Garcia-Pavia; Juan Delgado; Javier Segovia-Cubero; Valentín Fuster; Eulalia Roig; Joan Albert Barberá; Borja Ibanez; Ana García-Álvarez
Journal:  JACC Basic Transl Sci       Date:  2020-03-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.